Ignite Creation Date:
2024-05-05 @ 9:30 PM
Last Modification Date:
2024-10-26 @ 10:05 AM
Study NCT ID:
NCT00905047
Status:
COMPLETED
Last Update Posted:
2012-07-23
First Post:
2009-05-18
Brief Title:
Xeloda or UFT Tegafur-uracil With Folinic Acid in Advanced or Metastatic Colorectal Cancer
Sponsor:
Centre Oscar Lambret
Organization:
Centre Oscar Lambret
Study Overview
Official Title:
Open Comparative Study With a Cross-over According to PatientsPreference Receiving Xeloda or UFT With Folinic Acid in Advanced or Metastatic Colo-rectal Cancer
Status:
COMPLETED
Status Verified Date:
2012-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
COLOCROSS
Brief Summary:
The scope of the trial is to determine the preference of patients after randomization and cross-over for one of the two treatments
Another objective of the trial is to assess and compare the safety of each treatment
Another objective of the trial is to assess and compare the safety of each treatment
Detailed Description:
Further study details as provided by Centre Oscar Lambret
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None